Finasteride Tablet, Film Coated
Product Images NDC 50090-7228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 50090-7228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Address.jpg (Address)

FDA Label Image

Address3.jpg (Address3)

FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A line graph comparing mean change from baseline over four years between Finasteride and placebo groups. The y-axis shows the mean change with standard error, and the x-axis labels time points: baseline, year 1 through year 4. The Finasteride group shows a decreasing trend, while the placebo group remains near baseline.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A line graph titled 'Figure 2 Percent of Patients Having Surgery for BPH, Including TURP' compares the percent of patients undergoing surgery over a 48-month observation period between those treated with Finasteride and a placebo. The graph shows two lines, one for Finasteride and one for placebo, with the placebo group having a higher percentage over time. Below the graph, cumulative event counts and at-risk patient numbers are displayed for both groups at various time points.*
FDA Label Image

Figure3.jpg (Figure3)

Figure3.jpg (Figure3)
A line graph showing mean percent change from baseline over four years comparing placebo and Finasteride groups. The x-axis represents time points from baseline to year four, and the y-axis shows percent change. The placebo group shows increasing positive percent change, while the Finasteride group shows decreasing negative percent change over time.*
FDA Label Image

Figure4.jpg (Figure4)

Figure4.jpg (Figure4)
A line graph showing cumulative percent with event on the y-axis and years from randomization on the x-axis up to 5.5 years. It compares four groups labeled Placebo, Finasteride, Doxazosin, and Combination, illustrating trends in event percentages over time.*
FDA Label Image

Label Image (Lbl500907228)

Label Image (Lbl500907228)
Finasteride 5 mg film-coated tablets label from A-S Medication Solutions. The label states 5 mg per tablet, with storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from light. The package contains 90 tablets. Distributed by A-S Medication Solutions, Libertyville, Illinois.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of Finasteride, showing its molecular framework with labeled atoms and bonds characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.